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To describe the patient population, priority diseases and outcomes in newborns admitted
<48 hours old to neonatal units in both Kenya and Nigeria.
Study design
In a network of seven secondary and tertiary level neonatal units in Nigeria and Kenya, we
captured anonymised data on all admissions <48 hours of age over a 6-month period.
Results
2280 newborns were admitted. Mean birthweight was 2.3 kg (SD 0.9); 57.0% (1214/2128)
infants were low birthweight (LBW; <2.5kg) and 22.6% (480/2128) were very LBW (VLBW;
<1.5 kg). Median gestation was 36 weeks (interquartile range 32, 39) and 21.6% (483/2236)
infants were very preterm (gestation <32 weeks). The most common morbidities were jaun-
dice (987/2262, 43.6%), suspected sepsis (955/2280, 41.9%), respiratory conditions (817/
2280, 35.8%) and birth asphyxia (547/2280, 24.0%). 18.7% (423/2262) newborns died; mor-
tality was very high amongst VLBW (222/472, 47%) and very preterm infants (197/483,
40.8%). Factors independently associated with mortality were gestation <28 weeks
(adjusted odds ratio 11.58; 95% confidence interval 4.73–28.39), VLBW (6.92; 4.06–11.79),
congenital anomaly (4.93; 2.42–10.05), abdominal condition (2.86; 1.40–5.83), birth
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asphyxia (2.44; 1.52–3.92), respiratory condition (1.46; 1.08–2.28) and maternal antibiotics
within 24 hours before or after birth (1.91; 1.28–2.85). Mortality was reduced if mothers
received a partial (0.51; 0.28–0.93) or full treatment course (0.44; 0.21–0.92) of dexametha-
sone before preterm delivery.
Conclusion
Greater efforts are needed to address the very high burden of illnesses and mortality in hos-
pitalized newborns in sub-Saharan Africa. Interventions need to address priority issues dur-
ing pregnancy and delivery as well as in the newborn.
Introduction
Globally, 2.5 million infants died in the neonatal period (before age 28 days) in 2018. Neonatal
deaths accounted for 47% of all under 5 deaths and this proportion is increasing [1]. The
majority of neonatal deaths occur in the first week of life and are preventable with equitable
access to adequate, evidence-based maternal and newborn health care [2]. Sub-Saharan Africa
(SSA) bears a high burden of adverse neonatal outcomes and is the region where the least
progress has been made in addressing neonatal morbidity and mortality [1, 3]. The third Sus-
tainable Development Goal emphasises the need to end preventable newborn deaths with a
target for all countries to reduce the neonatal mortality rate (NMR) to 12 per 1000 live births
or lower by 2030 [4].
Globally, preterm (gestation <37 weeks) and low birthweight (LBW; <2.5 kg) infants have
an increased risk of mortality in the neonatal and post neonatal periods [5, 6]. Over 97% of
these infants are born in resource-limited settings [5, 7–9]. Indeed, complications of preterm
birth are now the leading cause of under 5 deaths accounting for 18% [1, 10]. Intrapartum-
related events and neonatal sepsis are other major causes of under 5 mortality [1].
Nigeria and Kenya are both ranked as lower-middle income countries by the United
Nations [11]. The NMR has halved in both countries over the past five decades but they remain
amongst the countries with the highest NMR in SSA, with the estimated NMR in 2018 in Nige-
ria of 39 per 1000 live births and in Kenya 19.6 per 1,000 live births [12, 13]. Both countries are
unlikely to meet the SDG target at their current rate of progress [3].
Reliable estimates of underlying causes of newborn morbidity and mortality are a pre-req-
uisite for evidence-based policy-making, advocacy and priority setting for future research [14].
Unfortunately, in many SSA countries including Nigeria and Kenya, health information sys-
tems are inadequate [15, 16]. Routine clinical data on common, serious neonatal conditions
such as preterm birth, low birthweight (LBW), birth asphyxia, sepsis and respiratory disorders
in hospitalised infants are sparse [17–19]. This lack of routine patient data, alongside the lim-
ited engagement of health professionals managing these infants in research, inhibits the devel-
opment of context relevant strategies and novel interventions to improve outcomes.
We established the Neonatal Nutrition Network (NeoNuNet) consisting of five neonatal
units (NNUs) in Nigeria and two in Kenya to share expertise and experience to improve clini-
cal outcomes across the Network and provide a platform for the development and evaluation
of nutrition and other key interventions for the most at risk preterm/LBW infants. In the first
phase a shared database of anonymised routine clinical data was therefore established to
describe the patient population, priority diseases and outcomes in newborns admitted <48
hours old to inform the development of context-relevant interventions in these SSA NNUs.
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Methods
Ethics approval
The study was approved by the Research and Ethics Committee at the Liverpool School of
Tropical Medicine (protocol number:18–0210), The Lagos University Teaching Hospital
Health Research Ethics Committee (protocol number: AMD/DCST/HREC/APP/2514), The
Kenya Medical Research Institute-Scientific and Ethics Review Unit (protocol number:
KEMRI/SERU/CGMR-C/120/3740) and the research and ethics committees at The Jaramogi
Oginga Odinga Teaching and Referral Hospital (protocol number: ERC.IB/VOL.1/510), Uni-
versity College Hospital Ibadan (protocol number: UI/EC/18/0446), Massey Street Children’s
Hospital (protocol number: LSHSC/2222/VOL.VIB/185), Ahmadu Bello University Teaching
Hospital (ABUTH/HZ/HREC/D37/2018), and Maitama District Hospital (protocol number:
FHREC/2018/01/108/19-09-18).
Study setting
The study was conducted in five NNUs in Nigeria of which four provide tertiary level care (Uni-
versity College Hospital, Ibadan; Lagos University Teaching Hospital, Massey Children’s Hospi-
tal, Lagos; Ahmadu Bello University Teaching Hospital, Zaria) and one secondary level
neonatal care (Maitama District Hospital, Abuja) and two in Kenya: Jaramogi Oginga Odinga
Teaching and Referral Hospital, Kisumu providing tertiary level and Kilifi County Referral Hos-
pital secondary level neonatal care. In Nigeria, the Nigeria Society of Neonatal Medicine led in
the selection of these facilities and aimed to incorporate neonatal units from both the northern
and southern parts of the country. In Kenya, the facilities were chosen based on previous collab-
orative partnerships aiming to include neonatal units that provide different levels of care i.e. ter-
tiary and district level in different regions of the country. The basis of this selection process was
prior research and clinical training collaborative partnerships between the Liverpool School of
Tropical Medicine (LSTM) co-investigators and clinical researchers in Nigeria and Kenya. All
neonatal units admitted both inborn and outborn infants<28 days of age. All neonatal units
except one in Kenya hadseparate rooms/wards for admitting inborn and outborn neonates. The
tertiary level units typically had 2–4 consultant neonatologists or paediatricians who supervised
resident doctors/registrars, intern house officers, clinical officers and a team of 1–3 nurses per
shift. In all the units, the neonates were admitted by intern house officers, medical officers or
clinical officers and were reviewed by a consultant neontologist or paediatrician daily during
their admission. The bed capacity ranged from 24–80 but occupancy often exceeded 100%. The
district level NNUs had 1–3 consultant paediatricians who worked with medical officers, clinical
officers and a team of 2–3 nurses per shift. The bed capacity ranged from 12–27. The NNUs
provide care according to institutional neonatal protocols in Nigeria and the Kenya national
paediatric protocol [20]. All the NNUs had access to oxygen, pulse oximetry and phototherapy
but these were often limited in availability and, therefore, reserved for the sickest newborns. All
the tertiary level NNUs and one of the district level NNUs used non-invasive ventilation (i.e.
continuous positive airway pressure), but none used endotracheal ventilation.
Study design, study population and data collection
This was a multi-centre, prospective, observational study. During network meetings held
before data collection, we established a standardised case report form (CRF) and an anon-
ymised demographic/clinical database. Clinical criteria, laboratory analyses and imaging cur-
rently used for the diagnosis of common neonatal morbidities were reviewed and additional
CRFs developed to capture episodes of suspected sepsis, respiratory problems, abdominal
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conditions and birth asphyxia diagnosed according to current clinical practice in each NNU.
The CRFs are available from https://www.lstmed.ac.uk/nnu. All newborns aged<48 hours
admitted to each NNU over a 6-month period between August 2018 and May 2019 were
included in the study and had CRFs completed with the period of data collection determined
by timing of ethics approval. Infants who were� 48 hours of age at admission were excluded
because we wanted to optimize recall of information on feeding practices from birth. In addi-
tion, infants aged 48 hours and above were generally admitted to paediatric wards rather than
neonatal units. Details of maternal demography, socioeconomic status, health and the current
pregnancy were recorded from ante-natal records. Details of labour and delivery were col-
lected from hospital records. Paper CRFs were kept as part of infant case records or stored sep-
arately and updated during NNU admission. Details of clinical criteria used to diagnose infant
conditions were recorded in separate forms, the analyses of which are provided in a separate
manuscript that is in preparation.
Data management
Data clerks in each NNU entered data into a REDcap database (http://www.project-redcap.org/
), that was hosted by the Liverpool School of Tropical Medicine (LSTM). Infants were identified
by a unique study number only and no personal identifiers were recorded in the database.
Data analysis
Categorical variables were presented as frequencies and percentages. Normally distributed var-
iables were reported using means and standard deviations (SDs) and median and interquartile
ranges (IQRs) were used for non-normally distributed variables. We analysed variables
according to country and level of care to provide some insights into the variability between
NNUs. When evaluating differences between individual NNUs, country and level of care, we
considered the clinical relevance of differences in variables as well as statistical significance.
Except for five variables with�10% missing data (maternal HIV status, hepatitis B, syphilis,
gestational diabetes, and infant length of admission), the average percentage of missing data
for variables ranged from 0–6.3%. The five variables with a high percentage of missing data
were not included in the multivariable logistic regression analysis. Univariate and multivari-
able logistic regression analyses identified factors associated with mortality with data imported
into Stata version 15.0 (Stata Corp). Multivariable logistic regression odds ratio plot was per-
formed by R V3.5.2. Kaplan-Meier survival analysis was used to estimate the independent
effects of gestation and birthweight on neonatal mortality. Mothers/infants with missing data
for a variable were not included in the analyses.
Information about the collection of anonymised data was displayed in each NNU; no
parents chose to opt-out of the study. At one of the Network sites, parents provided written
informed consent; 82 parents declined consent at this site.
Role of funding source
The funders of the study had no role in study design, data collection, data analysis, data inter-
pretation or writing of the report.
Results
Across the Network, anonymised data regarding 2280 infants admitted before age 48 hours
were collected. Almost all variables for maternal demography and health (Table 1), labour and
delivery (Table 2) and newborns (Tables 3 and 4) differed significantly amongst the NNUs.
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Table 1. Maternal demographics and health.
Variable TOTAL NIGERIA KENYA P value
1 2 3 4 5 6 7N = 2280
N = 100 N = 488 N = 226 N = 382 N = 208 N = 292 N = 584
Maternal age in years, n 2215 100 487 226 382 207 289 524
mean (SD) 28.7 (6.2) 30.8 (4.6) 30.6 (5.6) 31.0 (5.4) 31.2 (5.8) 28.7 (6.6) 25.7 (6.2) 25.6 (5.5)
<18, n (%) 48 (2.2) 0 (0) 3 (0.6) 0 (0) 0 (0) 4 (1.9) 18 (6.3) 23 (4.4) <0.001


















89 (43.0) 73 (25.3) 128
(24.4)
Maternal education, n 2146 100 467 226 382 206 287 478
Did not complete primary education, n (%) 297 (13.9) 2 (2.0) 14 (3.0) 0 (0) 19 (5.0) 53 (25.7) 126
(43.9)
83 (17.3) <0.001
Completed only primary school, n (%) 621 (28.9) 12 (12.0) 38 (8.1) 69 (30.5) 208
(54.4)
33 (16.0) 92 (32.1) 169
(35.4)
Completed secondary school, n (%) 533 (24.8) 15 (15.0) 165
(35.3)
43 (19.0) 99 (25.9) 41 (19.9) 30 (10.4) 140
(29.3)




56 (14.7) 79 (38.4) 39 (13.6) 86 (18.0)
Maternal occupation, n 2155 100 468 226 382 207 288 484









37 (17.9) 61 (21.2) 123
(25.4)
Junior schoolteachers/drivers, n (%) 320 (14.9) 7 (7.0) 169
(36.1)
30 (13.3) 43 (11.3) 15 (7.2) 23 (8.0) 33 (6.8)
Intermediate public servant/senior schoolteachers, n (%) 187 (8.7) 13 (13.0) 66 (14.1) 44 (19.5) 20 (5.2) 14 (6.8) 13 (4.5) 17 (3.5)
Senior public servant/ professionals/ large scale traders,
n (%)
159 (7.4) 24 (24.0) 52 (11.1) 23(10.2) 23 (6.0) 18 (8.7) 4 (1.4) 15 (3.1)
Marital status, n 2188 100 464 226 382 206 279 531
Single, n (%) 175 (8.0) 0 (0) 22 (4.7) 7 (3.1) 4 (1.0) 0 (0) 32 (11.5) 110
(20.7)
<0.001
















Divorced, n (%) 9 (0.4) 0 (0) 3 (0.7) 0 (0) 0 (0) 0 (0) 2 (0.7) 4 (0.8)
Parity, n 2216 100 486 226 382 207 292 523
0, n (%) 97 (4.4) 0 94 (19.3) 0 0 0 0 3 (0.6) <0.001
1, n (%) 624 (28.2) 21 (21.0) 125
(25.7)
69 (30.5) 88 (23.0) 47 (22.7) 97 (33.2) 177
(33.8)












Number of stillbirths, n 2222 100 486 226 382 207 292 529
One, n (%) 118 (5.3) 6 (6.0) 27 (5.6) 16 (7.1) 8 (2.1) 13 (6.3) 24 (8.2) 24 (4.5) <0.001
Two or more, n (%) 38 (1.7) 2 (2.0) 4 (0.8) 13 (5.8) 5 (1.3) 2 (0.9) 6 (2.1) 6 (1.2)
Antenatal clinic visits, n 2140 98 481 225 380 199 290 467



















Eight or more, n (%) 243 (11.4) 17 (17.4) 132
(27.4)
15 (6.6) 21 (5.5) 39 (19.6) 7 (2.4) 12 (2.5)
Number of foetuses, n 2267 100 483 226 382 207 292 577
(Continued)
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Maternal characteristics (Table 1)
Mean age was 28.7 years (SD 6.2) and only 48 mothers were <18 years. A minority of mothers
had not completed primary education (297/2146, 13.9%), over a third were unemployed or
housewives (i.e. did not work out of the house) (809/2255, 37.5%) and 8.0% (175/2189) were
single. Two thirds of mothers were multiparous (1495/2216, 67.4%) and 156/2222 (7.0%) had
had at least one stillbirth. Over one third of mothers (824/2140, 38.5%) had attended less than
four antenatal clinics and almost 1 in 5 (442/2267; 19.5%) had a multiple pregnancy. Age, edu-
cation levels and employment status were lower in the Kenyan than Nigerian NNUs and in
secondary than tertiary level NNUs. The proportion of single mothers was higher in Kenya
than Nigeria (S1 Table in S1 File).
Availability of data from ante-natal records varied markedly between NNUs. Overall, 128/
2039 (6.3%) mothers were HIV positive with a higher proportion in the Kenya than Nigeria
NNUs (S1 Table in S1 File). Hepatitis B prevalence was 2.4% in Nigeria but was rarely tested in
Kenya (S1 Table in S1 File). Syphilis positivity was low (2/1388; 0.1%). Pregnancy induced
hypertension (363/2136, 17.0%) and antepartum haemorrhage (161/2184, 7.4%) were com-
mon complications of pregnancy but gestational diabetes was less common (34/1755; 1.9%).
Labour and delivery (Table 2)
Most births were facility-based (2128/2280; 93.3%). Risk factors for perinatal sepsis were com-
mon among mothers; 359/2151 (16.7%) had rupture of membranes�18 hours and 204/2159
(9.5%) had confirmed or suspected peripartum fever. More than half of mothers had received
treatment with antibiotics within 24 hours before or after birth (1263/2147, 58.8%). 10.6%
(115/1083) of mothers of preterm infants received four doses of antenatal dexamethasone.
Almost half of deliveries were either vaginal assisted or by Caesarean section. Maternal mortal-
ity was 1.1% (24/2267).
Table 1. (Continued)
Variable TOTAL NIGERIA KENYA P value
1 2 3 4 5 6 7N = 2280
N = 100 N = 488 N = 226 N = 382 N = 208 N = 292 N = 584













2, n (%) 337 (14.9) 7 (7.0) 59 (12.2) 36 (15.9) 73 (19.1) 25 (12.1) 48 (16.4) 89 (15.4)
3–5, n (%) 105 (4.6) 3 (3.0) 13 (2.7) 11 (4.9) 54 (14.1) 6 (2.9) 3 (1.0) 15 (2.6)
HIV status, n 2039 95 365 225 346 173 270 565
Positive, n (%) 128 (6.3) 2 (2.1) 6 (1.6) 7 (3.1) 8 (2.3) 2 (1.2) 11 (4.1) 92 (16.3) <0.001
Hepatitis B, n 1079 91 242 224 345 159 1 17
Positive, n (%) 25 (2.3) 2 (2.2) 11 (4.6) 2 (0.9) 7 (2.0) 3 (1.9) 0 (0) 0 (0) 0.24
Syphilis, n 1388 93 122 225 65 127 252 504
Positive, n (%) 2 (0.1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (0.4) 0.74
Gestational diabetes, n 1755 95 460 225 35 164 241 535
Yes, n (%) 34 (1.9) 1 (1.0) 14 (3.0) 11 (4.9) 5 (14.3) 0 (0) 1 (0.4) 2 (0.4) <0.001
Pregnancy induced hypertension, n 2136 95 471 225 355 188 263 539
Yes, n (%) 363 (17.0) 15 (15.8) 76 (16.1) 51 (22.7) 110
(31.0)
41 (21.8) 16 (6.1) 54 (10.2) <0.001
Antepartum haemorrhage, n 2184 97 478 226 379 194 268 542
Yes, n (%) 161 (7.4) 7 (7.2) 44 (9.2) 14 (6.2) 41 (10.8) 12 (6.2) 19 (7.1) 24 (4.4) 0.010
https://doi.org/10.1371/journal.pone.0244109.t001
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Newborn admission characteristics (Table 3)
Most infants were male (1292/2280, 56.7%). Mean birth weight was 2.3 kg (SD 0.9); over half
of admissions were LBW (1214/2182, 55.6%) and about one in five (480/2182, 22.0%) were
VLBW. Methods used to assess gestation varied markedly between NNUs with last menstrual
period being the most common method (1587/2245, 70.7%). Median gestation was 36 weeks
(IQR 32, 39). Over half of admissions were preterm (1172/2236, 52.4%) and about one in five
were very preterm (gestation <32 weeks; 483/2236; 21.6%). Nearly half of all infants received
prophylactic antibiotics (1113/2252, 49.4%; defined as infants with risk factors for sepsis but
without clinical features of sepsis).
Morbidity and mortality in infants (Table 4)
Jaundice was the commonest morbidity (987/2262, 43.6%; defined as an infant treated with
phototherapy), with greater frequency reported from the NNUs in Nigeria. Other common
Table 2. Labour and delivery.
Variable Total NIGERIA KENYA P value
1 2 3 4 5 6 7N = 2280
N = 100 N = 488 N = 226 N = 382 N = 208 N = 292 N = 584
Place of delivery, n 2280 100 488 226 382 208 292 584

















Home, n (%) 99 (4.4) 1 (1.0) 17 (3.5) 9 (4.0) 8 (2.1) 29 (13.9) 22 (7.5) 13 (2.2)
Other, n (%)� 53 (2.3) 1 (1.0) 28 (5.7) 4 (1.8) 10 (2.6) 0 (0) 8 (2.7) 2 (0.4)
Rupture of membranes� 18 hours, n 2151 97 480 223 377 207 285 482




51 (22.9) 77 (20.4) 33 (15.9) 27 (9.5) 52 (10.8) <0.001
Maternal peripartum fever, n 2159 94 473 221 380 198 287 506
Confirmed or suspected, n (%) 204 (9.5) 21
(22.3)
45 (9.5) 13 (5.9) 13 (3.4) 40 (20.2) 25 (8.7) 47 (9.3) <0.001
Mother treated with antibiotics within 24 hrs before/after
birth, n
2147 90 423 217 375 193 281 568








75 (38.9) 41 (14.6) 534
(94.0)
<0.001
Mother <37 gestational weeks received antenatal
dexamethasone, n
1083 29 237 129 302 62 109 215
Full 4 doses, n (%) 115 (10.6) 3 (10.3) 50 (21.1) 27 (20.9) 13 (4.3) 6 (9.7) 0 (0) 16 (7.4) <0.001
1–3 doses, n (%) 171 (15.8) 7 (24.1) 33 (13.9) 42 (32.6) 55 (18.2) 24 (38.7) 1 (0.9) 9 (4.2)










Mode of delivery, n 2277 100 488 226 380 208 291 584










89 (42.8) 71 (24.4) 212
(36.3)
<0.001
Vaginal assisted, n (%) 83 (3.6) 3 (3.0) 15 (3.1) 9 (4.0) 7 (1.8) 11 (5.3) 23 (7.9) 15 (2.6)














Maternal outcomes, n 2267 100 486 226 380 206 292 577
Maternal death, n (%) �� 24 (1.1) 1(1.0) 13 (2.7) 5 (2.2) 5 (1.3) 0 (0) 0 (0) 0 (0) <0.001
�Top three: 20 at the mission home, 20 at traditional birth attendant home, and 7 delivered on the way to hospital
�� Top four: postpartum haemorrhage (n = 7), eclampsia (n = 5), cardiac or pulmonary compromise (n = 4), HIV encephalopathy (n = 2).
https://doi.org/10.1371/journal.pone.0244109.t002
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conditions included suspected sepsis (955/2280, 41.9%), respiratory conditions (817/2280,
35.8%), birth asphyxia (547/2280, 24.0% in all infants but 463/1371, 33.8% among infants�35
weeks gestation) and congenital anomalies (128/2269, 5.6%). Of the 128 infants who were
diagnosed with congenital abnormalities, 35 died during admission. These included: 10 with
gastrointestinal abnormalities (1 with jejunal atresia, 1 with duodenal atresia, 1 with a gastric
mass, 4 with gastroschisis, 3 with omphalocele), 6 with central nervous system abnormalities
(2 with hydrocephalus, 2 with lumbar myelomeningocele, 1 with frontal encephalocele, 1 with
microcephaly), 5 with cartilage and limb abnormalities (1 with achondroplasia, 1 with chron-
drodysplasia, 1 congenital amputation of the right foot, 1 with genu recurvatum, 1 with con-
genital talipes), 4 with heart disease (both cyanotic and acyanotic), 2 with facial abnormalities
(1 with cleft lip and palate, 1 with syngnathia) and 8 with other anomalies. An abdominal con-
dition (including necrotising enterocolitis) occurred in 71/2280 (3.1%) infants with a fre-
quency of 3.7% (45/1214) amongst LBW infants and 4.8% (23/483) amongst those with
gestation <32 weeks.
Table 3. Newborns on admission.
Variable Total NIGERIA KENYA P value
1 2 3 4 5 6 7N = 2280
N = 100 N = 488 N = 226 N = 382 N = 208 N = 292 N = 584
Gender, n 2280 100 488 226 382 208 292 584
Male, n (%) 1292 (56.7) 60 (60.0) 288 (59.0) 125 (55.3) 181 (47.4) 120 (57.7) 183 (62.7) 335 (57.4) 0.003
Birth weight, kg, n 2182 94 444 224 380 180 281 579
Birth weight, mean (SD) 2.3 (0.9) 2.7 (0.8) 2.4 (0.9) 2.3 (1.0) 1.8 (0.7) 2.5 (0.9) 2.4 (0.9) 2.5 (0.9) <0.001
<1, n (%) 107 (4.9) 0 (0) 17 (3.8) 16 (7.1) 34 (9.0) 3 (1.7) 15 (5.4) 22 (3.8)
1-<1.5, n (%) 373 (17.1) 11 (11.7) 77 (17.3) 51 (22.8) 94 (24.7) 19 (10.6) 43 (15.3) 78 (13.5)
1.5-<2.5, n (%) 734 (33.6) 20 (21.3) 140 (31.5) 63 (28.1) 204 (53.7) 70 (38.9) 72 (25.6) 165 (28.5)
2.5-<4, n (%) 909 (41.7) 57 (60.6) 198 (44.5) 83 (37.1) 48 (12.6) 80 (44.4) 147 (52.3) 296 (51.1)
4–5.5, n (%) 59 (2.7) 6 (6.4) 12 (2.7) 11 (4.9) 0 (0) 8 (4.4) 4 (1.4) 18 (3.1)
Gestation, weeks, n 2236 98 482 225 381 208 292 550
median (IQR) 36 (32, 39) 38 (34, 39) 36 (32, 39) 35 (30, 38) 33 (30, 35) 38 (36, 40) 38 (33, 40) 37 (33, 39)
<28, n (%) 119 (5.3) 0 (0) 24 (5.0) 13 (5.8) 40 (10.5) 0 (0) 14 (4.8) 28 (5.1) <0.001
28-<32, n (%) 364 (16.3) 8 (8.2) 93 (19.3) 55 (24.4) 102 (26.8) 9 (4.3) 37 (12.7) 60 (10.9)
32-<37, n (%) 689 (30.8) 27 (27.6) 134 (27.8) 69 (30.7) 169 (44.4) 57 (27.4) 65 (22.3) 168 (30.6)
37–42, n (%) 981 (43.9) 60 (61.2) 220 (45.6) 85 (37.8) 68 (17.8) 140 (67.3) 141 (48.2) 267 (48.5)
42–45, n (%) 83 (3.7) 3 (3.0) 11 (2.3) 3 (1.3) 2 (0.5) 2 (1.0) 35 (12.0) 27 (4.9)
Method used to assess gestation, n 2245 99 482 226 382 208 292 556
Ballard or other charts, n (%) 425 (18.9) 0 (0) 18 (3.7) 13 (5.8) 5 (1.3) 136 (65.4) 239 (81.9) 14 (2.5) <0.001
Early USS, n (%) 233 (10.4) 5 (5.1) 143 (29.7) 64 (28.3) 6 (1.6) 8 (3.9) 1 (0.3) 6 (1.1)
Maternal last menstrual period, n (%) 1587 (70.7) 94 (94.9) 321 (66.6) 149 (65.9) 371 (97.1) 64 (30.8) 52 (17.8) 536 (96.4)
Admitted to NNU from, n 2280 100 488 226 382 208 292 584
Home, n (%) 131 (5.8) 13 (13.0) 22 (4.5) 10 (4.2) 16 (4.2) 43 (20.7) 19 (6.5) 8 (1.4) <0.001
Labour ward, n (%) 910 (39.9) 19 (19.0) 234 (48.0) 137 (60.6) 111 (29.1) 105 (50.5) 91 (31.2) 213 (36.5)
Postnatal ward, n (%) 202 (8.9) 39 (39.0) 15 (3.1) 1 (0.4) 1 (0.3) 20 (9.6) 61 (20.9) 65 (11.1)
Health facility, n (%) 660 (28.9) 13 (13.0) 207 (42.4) 78 (34.5) 62 (16.2) 31 (14.9) 116 (39.7) 153 (26.2)
Other, n (%)� 377 (16.5) 16 (16.0) 10 (2.0) 0 (0) 192 (50.3) 9 (4.3) 5 (1.7) 145 (24.8)
Prophylactic antibiotics, n 2252 96 485 224 381 207 292 567
Yes, n (%) 1113 (49.4) 66 (68.8) 269 (55.5) 132 (58.9) 370 (97.1) 126 (60.9) 33 (11.3) 117 (20.6) <0.001
�348 from theatre, and 22 from the clinics or wards; ��Multiple choice.
https://doi.org/10.1371/journal.pone.0244109.t003
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Table 4. Morbidity and mortality in infants.
Variable TOTAL NIGERIA KENYA P value
1 2 3 4 5 6 7N = 2280
N = 100 N = 488 N = 226 N = 382 N = 208 N = 292 N = 584
Congenital anomalies, n 2269 100 486 225 378 206 292 582
Yes, n (%) 128 (5.6) 1 (1.0) 44 (9.1) 13 (5.8) 4 (1.1) 7 (3.4) 19 (6.5) 40 (6.9) <0.001
Congenital heart diseases, n 2234 99 473 226 367 203 292 574
Yes, n (%) 56 (2.5) 0 (0) 37 (7.8) 7 (3.1) 0 (0) 2 (1.0) 4 (1.4) 6 (1.1) <0.001
Patent ductus arteriosus among infant birth weight <1.5kg,
n
468 11 93 67 127 20 57 93
Yes, n (%) 17 (3.6) 0 (0) 13 (14.0) 1 (1.5) 0 (0) 1 (5.0) 1 (1.8) 1 (1.1) <0.001
Received phototherapy, n 2262 100 484 226 380 204 291 577










47 (16.2) 59 (10.2) <0.001
Other common morbidities 2280 100 488 226 382 208 292 584




42 (18.6) 38 (10.0) 49 (23.4) 53 (18.2) 180
(30.8)
<0.001






21 (5.5) 18 (8.7) 85 (29.1) 316
(54.1)
<0.001
Abdominal condition, n (%) 71 (3.1) 6 (6.0) 26 (5.3) 18 (8.0) 10 (2.6) 3 (1.4) 2 (0.7) 6 (1.0) <0.001









Infant final outcome, n 2262 100 488 226 378 206 292 572
Absconded/discharge against medical, n (%) 42 (1.9) 2 (2.0) 17 (3.5) 2 (0.9) 7 (1.9) 5 (2.4) 8 (2.7) 1 (0.2) <0.001
Died, n (%) 423 (18.7) 4 (4.0) 83 (17.0) 36 (15.9) 106
(28.0)
36 (17.5) 43 (14.7) 115
(20.1)
Transferred out, n (%) 43 (1.9) 3 (3.0) 23 (4.7) 1 (0.4) 7 (1.8) 0 (0) 2(0.7) 7 (1.2)
Discharged home with morbidities, n (%) 55 (2.4) 4 (4.0) 18 (3.7) 2 (0.9) 1 (0.3) 6 (2.9) 14 (4.8) 10 (1.8)
















Timing of mortality in infants, n 421 4 81 36 106 36 43 115
Age at time of death in days, median (IQR) 2 (1, 5) 2.5 (1, 6) 3 (2, 6) 2 (1, 4) 2 (1, 4) 5 (3, 7) 2 (1, 5) 1 (1, 3)




21 (58.3) 33 (76.7) 100
(87.0)
0.003
7-<14 days, n (%) 59 (14.0) 1 (25.0) 17 (21.0) 4 (11.1) 10 (9.4) 13 (36.1) 4 (9.3) 10 (8.7)
15–30 days, n (%) 23 (5.5) 0 (0) 6 (7.4) 1 (2.8) 4 (3.8) 1 (2.8) 6 (14.0) 5 (4.3)
>30 days, n (%) 4 (0.9) 0 (0) 1 (1.2) 0 (0) 2 (1.9) 1 (2.8) 0 (0) 0 (0)
Final outcome among infants birth weight <1.5kg, n 472 11 94 67 125 21 58 96
Absconded/discharge against medical, n (%) 3 (0.6) 0 (0) 0 (0) 1 (1.5) 1 (0.8) 0 (0) 1 (1.7) 0 (0) 0.018




14 (66.8) 21 (36.2) 50 (52.1)
Discharged home with morbidities, n (%) 4 (0.9) 0 (0) 2 (2.1) 0 (0) 0 (0) 1 (4.8) 1 (1.7) 0 (0)




6 (28.6) 35 (60.4) 45 (46.9)
Transferred out, n (%) 6 (1.3) 0 (0) 3 (3.2) 0 (0) 2 (1.6) 0 (0) 0 (0) 1 (1.0)
Final outcome among infants birth weight <1.0kg, n 104 0 17 15 21 0.023
Absconded/discharge against medical, n (%) 0 0 0 0 0
Died, n (%) 81 (77.9) 0 12 (70.6) 11 (73.3) 18 (85.7)
Discharged home with morbidities, n (%) 0 0 0 0 0
Discharged home with no morbidities, n (%) 22 (21.2) 0 5 (29.4) 4 (26.7) 3 (14.3)
Transferred out, n (%) 1 (1.0) 0 0 0 0
Timing of mortality in infants birth weight <1.5kg, n 221 1 39 24 72 14 21 50
(Continued)
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Overall mortality during hospital admission was 18.7% (423/2262). Mortality was high
amongst VLBW infants (222/472; 47.0%) and most extremely LBW (<1.0kg) infants died (81/
104; 77.9%). Similarly, mortality was high amongst very preterm infants (197/483; 46.6%) and
most extremely preterm (gestation<28 weeks) infants died (84/117; 71.8%). The majority of
deaths were early neonatal deaths (335/421, 79.6%) with a median (IQR) age of death of 2 (1, 5)
days (Table 4). Kaplan-Meier survival curves according to birth weight and gestation are shown
in Figs 1 and 2 respectively. Survival was similar among infants with birth weight between 1.5-
<2.5kg and those with weight� 2.5 kg, but much lower in those with birth weight<1.5kg (log
rank test P<0.001). The Kaplan-Meier survival probability estimates at 30 days were about 0.9 for
infants with birthweight�1.5kg and 0.5 for VLBW infants. Similarly, survival was similar in
infants with gestation between 32-<37 weeks and those gestation�37 weeks, but much lower in
very preterm infants (log rank test P<0.001). The Kaplan-Meier survival probability estimates at
30 days were about 0.9 for infants with gestation�32 weeks and 0.5 for very preterm infants.
Of infants discharged home alive, the majority had no reported morbidities (1699/1754,
96.9%).
Factors associated with mortality in infants
In univariate analysis, the factor with the highest odds ratio for mortality was extreme prema-
turity (gestation <28 weeks). Other factors significantly associated with increased mortality
were twin delivery, antepartum haemorrhage, place of birth other than the health facility or
home (which included in the car or a mission home), mother treated with antibiotics within
24 hrs before or after birth, female infant, VLBW, smaller head circumference, shorter length,
gestation 28-<32 weeks, congenital anomaly, birth asphyxia, suspected sepsis, respiratory con-
dition and abdominal condition. Factors protective against mortality included higher maternal
education and occupation status, greater number of ANC visits and delivery by caesarean sec-
tion (S2 Table in S1 File).
In multivariable logistic regression analysis, gestation <28 weeks remained the factor with
the highest odds of death (adjusted odds ratio [AOR] 11.58, 95% confidence interval [CI] 4.73,
28.39). The following factors were also significantly associated with increased mortality: birth
weight <1.5kg (AOR 6.92, 95%CI 4.06, 11.79), congenital anomaly (AOR 4.93, 95% CI 2.42,
10.05), infant having at least one abdominal condition (AOR 2.86, 95% CI 1.40, 5.83), birth
asphyxia (AOR 2.44, 95%CI 1.52, 3.92), mother receiving treatment with antibiotics within 24
hours before or after birth (AOR 1.91, 95%CI 1.28, 2.85) and infant having a respiratory condi-
tion (AOR 1.46, 95%CI 1.08, 2.28). Mother receiving 1–3 doses (AOR 0.51, 95% CI 0.28, 0.93)
or four doses (AOR 0.44, 95%CI 0.21, 0.92) of antenatal dexamethasone for preterm deliveries
remained protective (Fig 3).
Table 4. (Continued)
Variable TOTAL NIGERIA KENYA P value
1 2 3 4 5 6 7N = 2280
N = 100 N = 488 N = 226 N = 382 N = 208 N = 292 N = 584
Age at time of death in days, median (IQR) 2 (1, 6) 3 (3, 3) 3 (1, 7) 2 (1, 3) 2 (1, 5) 5.5 (4, 8) 3 (1, 6) 1 (0, 5)






7 (50.0) 13 (61.9) 38 (76.0) 0.042
7-<14 days, n (%) 33 (14.9) 0 (0) 7 (17.9) 2 (8.3) 8 (11.1) 6 (42.9) 2 (9.5) 8 (16.0)
15–30 days, n (%) 19 (8.6) 0 (0) 5 (12.8) 0 (0) 4 (5.6) 0 (0) 6 (28.6) 4 (8.0)
>30 days, n (%) 4 (1.8) 0 (0) 1 (2.6) 0 (0) 2 (2.8) 1 (7.1) 0 (0) 0 (0)
https://doi.org/10.1371/journal.pone.0244109.t004
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Among infants with birth weight <1.5kg, factors associated with neonatal mortality were
being extremely preterm (AOR 8.59, 95%CI 4.12, 17.93) and mother receiving treatment with
antibiotics within 24 hours before or after birth (AOR 2.83, 95%CI 1.46, 5.50). Infant being
female (AOR 0.53, 95%CI 0.31, 0.92) and mother receiving 1–3 doses (AOR 0.45, 95%CI 0.20,
0.98) or 4 doses (AOR 0.28, 95%CI 0.11, 0.70) of antenatal dexamethasone for preterm deliver-
ies were protective (S3 Table in S1 File).
Discussion
Neonatal morbidity and mortality
We report a high burden of mortality in this prospective study of hospitalised newborns
admitted to secondary and tertiary NNUs in Nigeria and Kenya with an overall mortality rate
of 18.7%. Variability in mortality between NNUs was marked and ranged between 4.0–28.0%.
Mortality in our study is consistent with prospective studies of admissions to six NNUs in pub-
lic hospitals in Eastern Ethiopia (mortality of 20.0%) [21] and to a public teaching hospital in
Addis Ababa, Ethiopia (23.1%) [22]. In retrospective studies, mortality ranged from 13–38%
Fig 1. Kaplan Meier survival by birthweight category; Day 0–30 of admission.
https://doi.org/10.1371/journal.pone.0244109.g001
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in NNUs in Kenya [29, 30], 5.7–23.3% in Ethiopia [23, 24], 18.8% in Nigeria [25], 15.7% in
Cameroon [26] and 8.2% in Eritrea [27].
Significant variation in case mix likely contributes to the marked variability in mortality
between NNUs included in our study. Compared with the NNUs in Nigeria, maternal age,
level of education and employment status were lower and HIV infection rates higher in Kenya.
This suggests that the NNUs in Kenya served a more disadvantaged population which may be
a reflection of the Free Maternity Service policy implemented in all public (government-run)
hospitals in 2013 [28]. Interestingly, although this policy increased facility-based deliveries,
recent data suggests that it has not significantly reduced maternal or neonatal mortality [29].
The case mix also varied between secondary and tertiary level NNUs with more women who
were less educated and unemployed attending secondary level NNUs. Neonatal risk adjust-
ment scores, using combinations of vulnerability (e.g. VLBW, prematurity), biological (e.g.
common morbidities) and socioeconomic variables, will be important to compare outcomes
between different NNUs, levels of care and regions and inform research and quality improve-
ment initiatives, and are being developed specifically for low-resource settings [30].
Fig 2. Kaplan Meier survival by gestational age group; Day 0–30 of admission.
https://doi.org/10.1371/journal.pone.0244109.g002
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Consistent with data for all neonatal deaths [31, 32], 80% deaths occurred in the early neo-
natal period (0–6 days). In resource-limited settings, shortages of skilled staff [33] who recog-
nise danger signs and implement appropriate management strategies [34] remain a challenge
in neonatal care. In addition, access to essential equipment such as continuous positive airways
pressure to support complications such as respiratory distress syndrome [35] is often not
Fig 3. Multivariable logistic regression analysis of factors related to mortality. Missing data have not been included in the analysis. Variables with response rate
<90% were omitted from the analysis: HIV status (n = 2024), hepatitis B (n = 1073), syphilis (n = 1387), gestational diabetes (n = 1745), and length on admission
(n = 1967). Model performance: Log likelihood = -447.87216, R2 = 0.2792, n = 1,424, P<0.001.
https://doi.org/10.1371/journal.pone.0244109.g003
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available. Also, as families often incur out of pocket expenses for health care even in public
health facilities, this too may hinder quality of care offered to these vulnerable infants [36].
In the multivariable analysis, the highest OR for mortality were for gestation <28 weeks
(AOR 11.6, 95% CI 4.7–28.4) and LBW (AOR 6.9, 95% CI 4.1–11.8) and each occurred in
about 1 in 5 babies. Estimation of gestation is a challenge in LMICs due to inadequate access to
quality antenatal care [37]. Although inferior to an antenatal ultrasound scan, assessment
based on date of last menstrual period, the most common method in our study, has been
shown to be relatively reliable for the estimation of gestational age in LMICs [38]. Our findings
are consistent with the multivariable logistic regression analysis in the prospective studies in
Ethiopia, where both gestation <37 weeks and LBW were independently associated with mor-
tality in the multicentre study [21] and gestational age below mean value (<36.6 weeks) in the
single centre study [22]. In our analysis and the study by Desalaw et al., although not mutually
exclusive, both prematurity and LBW were retained in the multiple regression model suggest-
ing that preterm birth and intra-uterine growth restriction independently increase the risk of
mortality. These findings highlight the potential importance of determining the pathogenesis
of LBW as optimal management may vary according to underlying causes.
Congenital anomalies occurred in fewer infants (about 1 in 20) but were significantly asso-
ciated with mortality (AOR 4.9; 95%CI 2.4–10.1). Although not always preventable, congenital
anomalies may require referral to tertiary level care with specialised services; therefore, referral
pathways and resources to provide appropriate care need to be prioritised in these settings.
Abdominal conditions, including NEC, occurred less frequently (3.1% of all infants; 4.8% of
infants with gestation < 32 weeks), but were also independently associated with mortality
(AOR 2.9, 95%CI 1.4–5.8). NEC is a major disease of preterm infants that hinders the estab-
lishment of early nutrition. Optimising newborn feeding is particularly important in contexts
where parenteral nutrition is rarely available [39] but there is a lack of pragmatic feeding trials
in SSA [40].
Birth asphyxia was diagnosed in about 1 in 4 admissions (1 in 3 of those with gestation�35
weeks) and associated with increased mortality (AOR 2.4, 95% CI 1.5–3.9). Our findings are
consistent with other tertiary referral NNUs in SSA that receive the most complicated peripar-
tum cases [41, 42] and highlight the need for the review of both obstetric and neonatal proce-
dures based on WHO frameworks for improving the quality of maternal and newborn care
[43] particularly at referring facilities.
Most mothers (58.8%) received antibiotics within 24 hours before or after birth. Maternal
risk factors for sepsis including prolonged rupture of membranes and peripartum fever were
common (16.7% and 9.5% respectively) but antibiotic prescribing exceeded this suggesting
that mothers were given antibiotics as a routine despite WHO recommendations [44]. In addi-
tion, nearly half of the newborns received prophylactic antibiotics. Suspected sepsis occurred
frequently (42% infants) but was not retained in the final multivariable logistic regression
model. This likely reflects the poor reliability of clinical diagnosis to identify true sepsis as labo-
ratory investigations were largely unavailable in the Network NNUs. The high exposure to
antibiotics amongst both mothers and infants and the fact that maternal exposure to antibiot-
ics was independently associated with infant mortality (AOR 1.9, 95%CI 1.3–2.9) raises con-
cerns about the development of anti-microbial resistance in these settings.
Respiratory conditions were independently associated with mortality (AOR 1.57, 95%
CI1.08–2.28) and the timely administration of antenatal dexamethasone to mothers before
preterm delivery to prevent or ameliorate neonatal respiratory morbidity was associated with
lower mortality. However, additional cost effective interventions to prevent this high burden
of respiratory illness in newborns need to be evaluated including increased coverage of mater-
nal influenza immunisation [45, 46].
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Neonatal jaundice, requiring treatment with phototherapy, was the commonest neonatal
condition (43.6%) and more common in Nigeria than in Kenya. This may reflect differences
in newborn care practices and/or regional differences in the frequency of disorders causing
neonatal haemolysis such as glucose-6-phosphate dehydrogenase deficiency [47–50]. Although
jaundice is often mild, it can progress to kernicterus spectrum disorder, death and long-term
severe neurological sequelae in survivors [51–53]. Although we did not find an association
between neonatal jaundice and mortality and morbidity among survivors was low, long-term
follow-up of survivors may identify motor and cognitive impairments that were not apparent
at discharge.
The proportion of mothers <18 years was surprisingly low particularly among the NNUs in
Nigeria (0.5%). There are a number of potential reasons for this. Firstly, recruitment of infants
<48 hours of age would have excluded some infants delivered at home and presenting later in
the postnatal period and this group may have consisted predominantly of younger mothers.
Secondly, the out of pocket expenses, particularly at the tertiary NNUs, could have been pro-
hibitive for younger mothers, therefore hindering them from accessing specialist neonatal
care. An analysis of the 2013 Nigeria Demographic and Health Survey reported that nearly two
thirds of women did not deliver in health facilities and the odds of not using health services
during delivery were increased among younger women, unmarried women and those from
poor households [54]. Access to specialised neonatal care amongst younger and disadvantaged
mothers, merits further research.
Maternal mortality was 1.1%, which is much higher than the global estimates of ~0.2% but
similar to a multicentre retrospective observational study in tertiary centres in Nigeria (2.1%)
[55]. Eclampsia accounted for 5 maternal deaths and pregnancy induced hypertension was the
commonest maternal morbidity in the antepartum period. Pregnancy induced hypertension is
also associated with adverse neonatal outcomes including preterm/LBW births and stillbirths
[56]. A recent meta-analysis of over 800,000 women predominantly from hospital-based urban
populations in 24 SSA countries (including Nigeria) found that hypertensive disorders in preg-
nancy were common with the highest prevalence rates reported from Central and West African
countries [57]. The prevention, identification and management of hypertension should be
prioritised in women of childbearing age and in the intrapartum care of women in SSA.
Strengths and limitations
We consider that prospective data collection, data management systems to identify and
address missing data or discrepancies and strong leadership from the co-investigators at all
sites enhanced the quality of our data. However, our findings have a number of limitations.
Information regarding pregnancies and deliveries were extracted from health records which
led to missing data for some maternal health indicators. Most of the admissions in our study
were to tertiary level NNUs that are not representative of neonatal care services in Nigeria or
Kenya. In settings where health care is not always free at the point of access, the population of
mothers who are able to access tertiary referral level neonatal care may be more affluent.
Therefore, our data may not be representative of newborns of poorer households and/or
admissions to secondary care in SSA. With an observational study design, it is not possible to
ascertain cause-effect relationships. Finally, we were not able to establish post-discharge out-
comes which are critical for a comprehensive assessment of disease burden in this population.
Conclusion
This study provides comprehensive multicentre data on the characteristics and short-term out-
comes of hospitalised newborns in SSA that will support much needed priority setting for
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research and quality improvement in maternal and neonatal care [58]. We have identified a
high burden of preventable maternal and neonatal illnesses in Nigeria and Kenya with the
highest risk of mortality amongst very preterm and VLBW infants. Our findings emphasize
the importance of collaborative work involving maternal and neonatal health clinicians and
researchers working in partnership with families to develop strategies to prevent adverse neo-
natal outcomes that are often closely linked with poor maternal health outcomes [59].
Improved prevention and management of conditions that affect very preterm and VLBW
infants deserves to be a health and research priority.
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